Netflix blames its content slate, regional price increases and a "pull-forward effect" of its strong Q1 growth for the miss.Technologyread more
Netflix lost paid U.S. subscribers for the first time in eight years and fell below analyst estimates for international subscriber growth.Tech Driversread more
Despite a disappointing earnings report, Wall Street analysts are sticking by the stock and looking ahead to the third quarter.Marketsread more
The Dow Jones Industrial Average and Nasdaq Composite traded slightly lower on Thursday after a mixed batch of corporate earnings results.US Marketsread more
Revenue of $10.24 billion exceeded the consensus estimate by almost $250 million.Financeread more
Treasury Secretary Steven Mnuchin says if the call goes well, he would expect in-person meetings to take place.Marketsread more
Southwest joints United and American in taking the Boeing 737 Max out of its schedules through early November with no end in sight to the federally mandated grounding of the...Airlinesread more
Jeffrey Epstein, a former friend of presidents Donald Trump and Bill Clinton, had asked a judge to release him on a bond of as high as $100 million or more.Politicsread more
The filing came a day after the judge in Michael Cohen's criminal case ordered their release, saying that the end of a probe into those payments to alleged sexual partners of...Politicsread more
The strengthening of the president's formidable campaign war chest has led his organization, along with the Republican National Committee, to raise over $100 million in the...2020 Electionsread more
Raymond James upgraded Apple and said its most recent checks show Apple is preparing to bring a 5G iPhone to a wider range of models than previously thought.Marketsread more
Vodafone Group PLC: "This thing has been such a laggard, and every time that the stock goes down more and more, the yield gets bigger, and now I'm starting to wave the red flag. There's something wrong there. I don't trust it."
Arconic Inc.: "Oh, the predecessor to Alcoa. OK, here's the problem: it's at $21. If they don't get a buyer, the stock goes to $17. If they do get a buyer, they go to $23. So it's $3 up, $3 down. For me, that means don't buy. "
OptiNose Inc.: "I do not like the specialty pharmacy companies. I've been off them for three years. I'm not going there now."